We hypothesized that copeptin-based classification would demonstrate superior accuracy, reliability, and feasibility for identifying central diabetes insipidus (CDI), nephrogenic diabetes insipidus (NDI), and primary polydipsia (PP) in pediatric patients. This evidence concerns the gene AVP and clostridium difficile infection.